Stay updated on Granix Disruption in Myeloma Transplant Clinical Trial
Sign up to get notified when there's something new on the Granix Disruption in Myeloma Transplant Clinical Trial page.

Latest updates to the Granix Disruption in Myeloma Transplant Clinical Trial page
- Check4 days agoChange DetectedThe clinical trial record for a study of Granix with high-dose melphalan before autologous stem cell transplantation is displayed, with its study details and a protocol and statistical analysis plan document. The previous 403 error page is no longer shown.SummaryDifference56%

- Check11 days agoChange DetectedThe page remains a 403 Forbidden error, with the footer revision changing from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check18 days agoChange DetectedAn NIH announcement banner appears above the page, sharing updates about the agency’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology.SummaryDifference1%

- Check25 days agoChange DetectedThe ClinicalTrials.gov footer revision label changed from v3.7.1 to v3.7.2 while the study page continues to show a 403 error.SummaryDifference0.2%

- Check32 days agoChange DetectedThe footer revision label was updated from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check53 days agoChange DetectedThe page now displays a 403 Forbidden message and basic site chrome; detailed study content and links have been removed, indicating the study record is no longer accessible.SummaryDifference20%

Stay in the know with updates to Granix Disruption in Myeloma Transplant Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Granix Disruption in Myeloma Transplant Clinical Trial page.